Development and evaluation of PLGA polymer based nanoparticles of quercetin

International Journal of Biological Macromolecules

Volumn 92, Issue , 2016, Pages 213-219

  Anwer, Md Khalid ^a   Al Mansoor, Mohammed A ^a   Jamil, Shahid ^a   Al Shdefat, Ramadan ^a   Ansari, Mohammad Nazam ^a   Shakeel, Faiyaz ^b  

^a PRINCE SATTAM BIN ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Diuretic activity; PLGA nanoparticle; Quercetin

Indexed keywords

FUROSEMIDE; NANOPARTICLE; POLYGLACTIN; QUERCETIN; 1,1-DIPHENYL-2-PICRYLHYDRAZYL; ANTIOXIDANT; BIPHENYL DERIVATIVE; CARBONATE DEHYDRATASE INHIBITOR; ELECTROLYTE; LACTIC ACID; PICRIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSITY; DIURETIC ACTIVITY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG ENTRAPMENT EFFICIENCY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; PHARMACOLOGICAL PARAMETERS; PHYSICAL CHEMISTRY; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; RAT; SCANNING ELECTRON MICROSCOPY; ANIMAL; CHEMISTRY; ORAL DRUG ADMINISTRATION; STANDARD; ULTRASTRUCTURE; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BIPHENYL COMPOUNDS; CALORIMETRY, DIFFERENTIAL SCANNING; CARBONIC ANHYDRASE INHIBITORS; DRUG LIBERATION; ELECTROLYTES; LACTIC ACID; MALE; NANOPARTICLES; PARTICLE SIZE; PICRATES; POLYGLYCOLIC ACID; QUERCETIN; RATS, WISTAR; REFERENCE STANDARDS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84989929054     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2016.07.002     Document Type: Article

References (27)

1. [1] Lee, G.H., Lee, S.J., Jeong, S.W., Kim, H.C., Park, G.Y., Lee, S.G., Choi, J.H., Antioxidative and antiinflammatory activities of quercetin-loaded silica nanoparticles. Colloids Surf. B 143 (2016), 511–517.
2. [2] Murota, K., Terao, J., Anti-oxidative flavonoid pure quercetin: implications of its intestinal absorption and metabolism. Arch. Biochem. Biophys. 417 (2003), 12–17.
3. [3] Mounnissamy, V.M., Diuretic activity of quercetin isolated from Cansjera rheedii j. gmelin (opiliaceae). Int. J. Pharm. Arch. 4 (2015), 50–53.
4. [4] Kendre, P.N., Pande, V.V., Chavan, K.M., Novel formulation strategy to enhance solubility of quercetin. Pharmacophore 5 (2014), 358–370.
5. [5] Sun, D., Zhang, W., Li, N., Zhao, Z., Mou, Z., Yang, E., Wang, W., Silver nanoparticles-quercetin conjugation to siRNA against drug-resistant Bacillus subtilis for effective gene silencing: in vitro and in vivo. Mater. Sci. Eng. C: Mater. Biol. Appl. 63 (2016), 522–534.
6. [6] Wiczkowski, W., Nemeth, K., Bucinski, A., Piskuta, M.K., Bioavailability of quercetin from flesh scales and dry skin of onion in rats. Pol. J. Food Nutr. Sci. 12 (2003), 95–99.
7. [7] Graefe, E.U., Wittig, J., Mueller, S., Riethling, A.K., Uehleke, B., Drewelow, B., Pforte, H., Jacobasch, G., Derendorf, H., Veit, M., Pharmacokinetics and bioavailability of quercetin glycosides in human. J. Clin. Pharmacol. 41 (2001), 492–499.
8. [8] Kumar, A., Sahoo, S.K., Padhe, K., Kochar, P.P.S., Satpathy, A., Pathak, N., Review on solubility enhancement techniques for hydrophobic drugs. Pharm. Global Int. J. Comp. Pharm. 2 (2011), 1–7.
9. [9] Anwer, M.K., Jamil, S., Ansari, M.J., Iqbal, M., Imam, F., Shakeel, F., Development and evaluation of olmesartan medoxomil loaded PLGA nanoparticles. Mater. Res. Innov. 20 (2016), 193–197.
10. [10] Pawar, A.R., Choudhari, P.D., Novel techniques for solubility, dissolution rate and bioavailability enhancement of class II & IV drugs. Asian J. Biomed. Pharm. Sci. 13 (2012), 9–14.
11. [11] Millard, J.W., Alvarez-Nunez, F.A., Yalkowsky, S.H., Solubilization by cosolvents. Establishing useful constants for the log-linear model. Int. J. Pharm. Pharm. Sci. 245 (2002), 153–166.
12. [12] Wong, D.H., Kim, M.S., Lee, S., Jeong, S.P., Hwang, S.J., Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int. J. Pharm. 301 (2005), 199–208.
13. [13] Anwer, M.K., Jamil, S., Ansari, M.J., Al-Shdefat, R., Ali, B.E., Ganaie, M.A., Abdel-Kader, M.S., Shakeel, F., Water soluble binary and ternary complexes of diosmin with β-cyclodextrin: spectroscopic characterization, release studies and anti-oxidant activity. J. Mol. Liq. 199 (2014), 35–41.
14. [14] Kumari, A., Yadav, S.K., Yadav, S.C., Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B 75 (2010), 1–18.
15. [15] Zhang, S.Y., Wu, Y., He, B., Luo, K., Gu, Z.W., Biodegradable polymeric nanoparticles based on amphiphilic principle: construction and application in drug delivery systems. Sci. China Chem. 57 (2014), 461–475.
16. [16] Guerrero-Cazarest, H., Tzeng, S.Y., Young, N.P., Abutaleb, A.O., Quinones-Hinojosa, A., Green, J.J., Biodegradable polymeric nanoparticles show high efficacy and specificity at DNA delivery to human glioblastoma in vitro and in vivo. ACS Nano 8 (2014), 5141–5153.
17. [17] Danhier, F., Ansorena, E., Silva, J.M., Coco, R., Le Breton, A., Préat, V., PLGA-based nanoparticles: an overview of biomedical applications. J. Control. Release 161 (2012), 505–522.
18. [18] Jain, R.A., The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials 21 (2000), 2475–2490.
19. [19] Fatma, S., Talegaonkar, S., Iqbal, Z., Panda, A.K., Negi, L.M., Goswami, D.G., Tariq, M., Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations. Drug Deliv. 23 (2016), 500–511.
20. [20] Das, S., Roy, P., Pal, R., Auddy, R.G., Chakraborti, A.S., Mukherjee, A., Engineered silybin nanoparticles educe efficient control in experimental diabetes. PLoS One, 9, 2014, E101818.
21. [21] Pool, H., Quintanar, D., Figueroa, J.D., Mano, C.M., Bechara, J.E.H., Godínez, L.A., Mendoza, S., Antioxidant effects of quercetin and catechin encapsulated into PLGA nanoparticles. J. Nanomater. 2012 (2012), 1–12.
22. [22] Mokale, V.J., Naik, J.B., Verma, U., Patil, J.S., Yadava, S.K., Preparation and characterization of biodegradable glimepiride loaded PLA nanoparticles by o/w solvent evaporation method using high pressure homogenizer: a factorial design approach. SAJ Pharm. Pharmacol. 1 (2014), 1–10.
23. [23] Piovesan, J.V., Spinelli, A., Determination of quercetin in a pharmaceutical sample by square-wave voltammetry using a poly(vinylpyrrolidone)-modified carbon-paste electrode. J. Braz. Chem. Soc. 25 (2014), 517–525.
24. [24] Ansari, M.N., Ameliorative effect of Eruca sativa extracts on glucose and urinary volume in streptozotocin-induced diabetic rats. Int. J. Biol. Pharm. Allied Sci. 3 (2014), 1092–1100.
25. [25] Vogel, G.H., Drug Discovery and Evaluation: Pharmacological Assays. 2002, Springer-Verlag, Germany, 324–325.
26. [26] Quintanar-Guerrero, D., Fessi, H., Allemann, E., Doelker, E., Influence of stabilizing agents and preparatives variables on the formation of poly(D,L-lactic acid) nanoparticles by an emulsification-diffusion technique. Int. J. Pharm. 143 (1996), 133–141.
27. [27] Mainardes, R.M., Evangelista, R.C., PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int. J. Pharm. 290 (2005), 137–144.